Anh Tran Selected Research

Anh Tran Research Topics

Disease

5	Neoplasms (Cancer) 01/2021 - 01/2009
4	Glioblastoma (Glioblastoma Multiforme) 03/2013 - 01/2009
3	Infections 08/2022 - 01/2018
3	COVID-19 01/2022 - 01/2021
2	Virus Diseases (Viral Diseases) 01/2022 - 11/2021
2	Hepatocellular Carcinoma (Hepatoma) 01/2021 - 01/2018
2	Melanoma (Melanoma, Malignant) 08/2019 - 01/2018
2	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 03/2017 - 05/2015
2	Hemorrhage 05/2007 - 07/2005
1	Human Influenza (Influenza) 09/2021
1	Obesity 01/2021
1	Weight Loss (Weight Reduction) 01/2021
1	Neoplasm Metastasis (Metastasis) 01/2021
1	Breast Neoplasms (Breast Cancer) 01/2021
1	Carcinogenesis 01/2021
1	Severe Acute Respiratory Syndrome 01/2021
1	Multiple Organ Failure (MODS) 03/2020
1	Tuberculosis (Tuberculoses) 03/2020
1	Cancer Pain 11/2019
1	Substance Withdrawal Syndrome (Withdrawal Symptoms) 11/2019
1	Brain Neoplasms (Brain Tumor) 08/2019
1	Neuroinflammatory Diseases 03/2019
1	Head and Neck Neoplasms (Head and Neck Cancer) 01/2019
1	Hepatitis C 01/2019
1	Schistosomiasis (Bilharziasis) 12/2018
1	Strongyloidiasis 12/2018
1	Fatigue 03/2017
1	Cytopenia 03/2017
1	Glioma (Gliomas) 12/2011
1	Allergic Contact Dermatitis 03/2010
1	Cheilitis 03/2010
1	Contact Dermatitis (Eczema, Contact) 03/2010
1	Atherosclerosis 07/2009
1	Arterial Occlusive Diseases (Arterial Occlusive Disease) 07/2009
1	Thrombosis (Thrombus) 07/2009
1	Dyslipidemias (Dyslipidemia) 07/2009
1	Hypersensitivity (Allergy) 07/2009
1	Embolism (Embolus) 05/2007

Drug/Important Bio-Agent (IBA)

4	VaccinesIBA 01/2022 - 01/2021
3	Proteins (Proteins, Gene)FDA Link 08/2022 - 01/2021
2	AntibodiesIBA 11/2021 - 01/2019
2	LipidsIBA 09/2021 - 07/2009
2	SphingolipidsIBA 09/2021 - 01/2021
2	ibrutinibIBA 03/2017 - 05/2015
1	Fulvestrant (Faslodex)FDA Link 01/2021
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2021
1	Fibroblast Growth Factor Receptors (Fibroblast Growth Factor Receptor)IBA 01/2021
1	ribociclibIBA 01/2021
1	Biomarkers (Surrogate Marker)IBA 01/2021
1	Sorafenib (BAY 43-9006)FDA Link 01/2021
1	abemaciclibIBA 01/2021
1	palbociclibIBA 01/2021
1	infigratinibIBA 01/2021
1	Hormones (Hormone)IBA 01/2021
1	AgarIBA 03/2020
1	Pharmaceutical PreparationsIBA 03/2020
1	Indicators and Reagents (Reagents)IBA 03/2020
1	Isoniazid (Ftivazide)FDA LinkGeneric 03/2020
1	Rifampin (Rifampicin)FDA LinkGeneric 03/2020
1	zaleplon (Sonata)FDA LinkGeneric 11/2019
1	Antidepressive Agents (Antidepressants)IBA 11/2019
1	Gabapentin (Neurontin)FDA LinkGeneric 11/2019
1	zopiclone (Zop)IBA 11/2019
1	Zolpidem (Ambien)FDA LinkGeneric 11/2019
1	Opioid Analgesics (Opioids)IBA 11/2019
1	BenzodiazepinesIBA 11/2019
1	Pregabalin (Lyrica)FDA Link 11/2019
1	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 03/2019
1	Mitogen-Activated Protein Kinase 14IBA 03/2019
1	InterleukinsIBA 03/2019
1	Hepatitis B Surface Antigens (HBsAg)FDA Link 01/2019
1	TabletsIBA 01/2019
1	Praziquantel (Biltricide)FDA Link 12/2018
1	Ivermectin (Mectizan)FDA Link 12/2018
1	Antiviral Agents (Antivirals)IBA 01/2018
1	Agammaglobulinaemia Tyrosine KinaseIBA 05/2015
1	Bendamustine Hydrochloride FDA Link 05/2015
1	Rituximab (Mabthera)FDA Link 05/2015
1	fludarabineIBA 05/2015
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 05/2015
1	Protein MethyltransferasesIBA 03/2013
1	MethyltransferasesIBA 03/2013
1	KynurenineIBA 12/2012
1	Isocitrate Dehydrogenase (Isocitrate Dehydrogenase (NAD+))IBA 12/2011
1	Temozolomide (Temodar)FDA LinkGeneric 01/2011
1	Bevacizumab (Avastin)FDA Link 01/2011
1	Flavoring AgentsIBA 03/2010
1	peppermint oilIBA 03/2010
1	Sunscreening Agents (Sunscreens)IBA 03/2010
1	CD100 antigenIBA 07/2009
1	LDL Receptors (LDL Receptor)IBA 07/2009
1	Semaphorins (Semaphorin)IBA 07/2009
1	EnzymesIBA 01/2009
1	hydrogen sulfite (bisulfite)IBA 01/2009
1	DNA (Deoxyribonucleic Acid)IBA 01/2009
1	Low-Molecular-Weight Heparin (Heparin, Low Molecular Weight)IBA 05/2007

Therapy/Procedure

5	Therapeutics 01/2018 - 03/2017
2	Radiotherapy 08/2019 - 01/2011
1	Aftercare (After-Treatment) 01/2021
1	Length of Stay 05/2007